Skip to main content
Top
Published in: Abdominal Radiology 2/2016

01-02-2016

How to not miss alveolar echinococcosis in hepatic lesions suspicious for cholangiocellular carcinoma

Authors: J. Mueller, M. Stojkovic, A. K. Berger, K. D. Rosenberger, C. L. Schlett, H.-U. Kauczor, T. Junghanss, T. F. Weber

Published in: Abdominal Radiology | Issue 2/2016

Login to get access

Abstract

Purpose

Hepatic alveolar echinococcosis (AE) resembles intrahepatic cholangiocarcinoma (ICC) on radiological imaging. The purpose of this study was to identify criteria to discriminate AE from ICC with CT and MR Imaging.

Methods

One hundred and sixteen imaging studies of 94 patients (CT n = 65; MRI n = 51) diagnosed with AE (n = 55) or ICC (n = 39) were retrospectively reviewed by two blinded radiologists for lesion features including enhancement pattern and matrix composition. A consensus read was conducted in cases of disagreement. Uni- and multivariate logistic regression with bootstrapping were used for analysis.

Results

Using CT, no or septal enhancement and calcification yielded the highest values of sensitivity/specificity (90.9%/90.6% and 81.8%/96.9%) for AE. Using MRI, no or septal enhancement and cystic components achieved the highest sensitivity/specificity (90.9%/100.0% and 84.8%/66.7%) for AE. Multivariate logistic regression identified the following strong independent predictors for AE: for MRI, no or septal enhancement (odds ratio [OR] 322.4; p < 0.001); for CT, no or septal enhancement and calcification (OR 35.9 and 42.5; p < 0.001 and p < 0.01, respectively). No or septal enhancement and calcification demonstrated the highest interreader agreement (>90%).

Conclusion

Enhancement characteristics and matrix calcifications offer the strongest discriminating potential between AE and ICC with a high sensitivity, specificity, and interreader agreement.
Literature
8.
go back to reference Rozanes I, Acunas B, Celik L, Minareci O, Gokmen E (1992) CT in lobar atrophy of the liver caused by alveolar echinococcosis. J Comput Assist Tomogr 16(2):216–218CrossRefPubMed Rozanes I, Acunas B, Celik L, Minareci O, Gokmen E (1992) CT in lobar atrophy of the liver caused by alveolar echinococcosis. J Comput Assist Tomogr 16(2):216–218CrossRefPubMed
11.
go back to reference Torgerson PR, Schweiger A, Deplazes P, et al. (2008) Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol 49(1):72–77. doi:10.1016/j.jhep.2008.03.023 CrossRefPubMed Torgerson PR, Schweiger A, Deplazes P, et al. (2008) Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol 49(1):72–77. doi:10.​1016/​j.​jhep.​2008.​03.​023 CrossRefPubMed
12.
go back to reference Zeng C, Newcomer SR, Glanz JM, et al. (2013) Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design. Am J Epidemiol 178(12):1750–1759. doi:10.1093/aje/kwt211 CrossRefPubMed Zeng C, Newcomer SR, Glanz JM, et al. (2013) Bias correction of risk estimates in vaccine safety studies with rare adverse events using a self-controlled case series design. Am J Epidemiol 178(12):1750–1759. doi:10.​1093/​aje/​kwt211 CrossRefPubMed
13.
go back to reference Firth D (1993) Bias reduction of maximum likelihood estimates. Biometrika 80(1):27–38CrossRef Firth D (1993) Bias reduction of maximum likelihood estimates. Biometrika 80(1):27–38CrossRef
14.
go back to reference McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22(3):276–282CrossRef McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22(3):276–282CrossRef
18.
go back to reference Coskun A, Ozturk M, Karahan OI, et al. (2004) Alveolar echinococcosis of the liver: correlative color Doppler US, CT, and MRI study. Acta Radiol 45(5):492–498CrossRefPubMed Coskun A, Ozturk M, Karahan OI, et al. (2004) Alveolar echinococcosis of the liver: correlative color Doppler US, CT, and MRI study. Acta Radiol 45(5):492–498CrossRefPubMed
19.
go back to reference Katranci N, Elmas N, Yilmaz F, Mentes A (1999) Correlative CT, MRI and histological findings of hepatic Echinococcus alveolaris: a case report. Comput Med Imaging Graph 23(3):155–159CrossRefPubMed Katranci N, Elmas N, Yilmaz F, Mentes A (1999) Correlative CT, MRI and histological findings of hepatic Echinococcus alveolaris: a case report. Comput Med Imaging Graph 23(3):155–159CrossRefPubMed
23.
go back to reference Vuitton DA, Guerret-Stocker S, Carbillet JP, et al. (1986) Collagen immunotyping of the hepatic fibrosis in human alveolar echinococcosis. Z Parasitenkd 72(1):97–104CrossRefPubMed Vuitton DA, Guerret-Stocker S, Carbillet JP, et al. (1986) Collagen immunotyping of the hepatic fibrosis in human alveolar echinococcosis. Z Parasitenkd 72(1):97–104CrossRefPubMed
Metadata
Title
How to not miss alveolar echinococcosis in hepatic lesions suspicious for cholangiocellular carcinoma
Authors
J. Mueller
M. Stojkovic
A. K. Berger
K. D. Rosenberger
C. L. Schlett
H.-U. Kauczor
T. Junghanss
T. F. Weber
Publication date
01-02-2016
Publisher
Springer US
Published in
Abdominal Radiology / Issue 2/2016
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-015-0561-2

Other articles of this Issue 2/2016

Abdominal Radiology 2/2016 Go to the issue

Classics in Abdominal Imaging

The “double bubble” sign

Classics in Abdominal Imaging

The “molar tooth” sign

Classics in Abdominal Imaging

The stained glass window appearance

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine